Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Broker tips: Currys, Oxford Instruments

(Sharecast News) - Citi reiterated its 'buy' rating on Currys on Tuesday and lifted its price target on the stock to 150.0p from 121.0p, saying that iD Mobile and buybacks were set to provide material upside. The bank said that following around £50.0m working capital investments made in the last two years towards growing iD mobile, its proprietary cohort analysis suggests the benefits from the investment will become apparent in the near term.

Citi estimates that iD mobile will account for the majority of the roughly 2% per annum growth in UK & Ireland like-for-like sales it forecasts for FY26-28, implying "market conditions need not be favourable" if it hopes to sustain revenue expectations.

"We estimate that 30-45% of UK&I EBIT will come from iD mobile FY26e/FY27e/FY28e (versus circa 20% in FY25a), as the headwinds from ramp-up of newer cohorts fade," Citi said. "We believe iD Mobile alone is worth circa £600.0m or 45% of Currys' current market cap."

Citi also said it models £50.0m/£20.0m/£35.0m of buybacks in FY26/FY27/FY28, respectively, driving a cumulative earnings per share uplift of 1%/5%/7% in addition to the approximately 2%-3% dividend yield.

Analysts at Berenberg lowered their target price on manufacturing and research firm Oxford Instruments from 2,600.0p to 2,500.0p on Tuesday but noted the group had made a "quantum leap in cash" from self-help efforts.

Berenberg noted that Oxford Instruments was transitioning into a more commercially focused organisation, leveraging its "strong technology portfolio" with greater operational efficiency and rigour.

The German bank stated that it views Oxford Instruments' compound semiconductor exposure as "a key driver" of revenue and profit growth in the coming years.

"Following three years of flat operating profits and volatile cash generation, we forecast an inflection in the coming 12 months, said Berenberg. "The valuation is attractive, with scope for a re-rating as cash generation doubles by FY28E."

Bernberg also noted that with a 25% potential upside, it had opted to reiterate its 'buy' rating on the stock, adding that it sees scope for a re-rating as improved financial metrics are delivered.

Share this article

Related Sharecast Articles

Europe close: Stocks turn weaker on AI concerns
(Sharecast News) - European equities slipped into the red to close lower on Friday, surrendering earlier gains that followed a record-setting session on Wall Street overnight.
London close: Stocks erase early gains, end week lower
(Sharecast News) - The FTSE 100 failed to hold on to earlier gains by the close on Friday following a weak start on Wall Street, while UK investors continued to digest data showing an unexpected economic contraction in October.
Broker tips: Hvivo, Whitbread, IHG
(Sharecast News) - hVIVO traded higher on Friday on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
US open: Dow extends gains, Nasdaq weaker as traders eye Fed comments
(Sharecast News) - Wall Street trading got off to a mixed start on Friday after both the Dow Jones and S&P 500 wrapped up the previous session at all-time highs.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.